Novartis NVS Edges Lower Consolidation Phase Near Key Support Levels Stock Markets Edge Higher as Fundamentals Support Rally MCO Q1 2026 Earnings EPS Beats Estimates by 161 Amid Steady Performance Proposed Trump 250 Bill Sparks Currency Design Debate